Insider · CIK 0001957515
Cystic Fibrosis Foundation
Files at HLSQ (BiomX Inc.). First filing -, latest -.
In brief
Cystic Fibrosis Foundation files SEC Form 4 as 10% owner at HLSQ (BiomX Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Cystic Fibrosis Foundation has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 15, 2024 | HLSQ BiomX Inc. | XIn-the-money exercise Common Stock, par value $0.0001 per share | +4,778,265 | $0.00 | $4,778 | 9,330,580 | May 17, 2024 |
| May 15, 2024 | HLSQ BiomX Inc. | XIn-the-money exercise Warrant to purchase common stockderivative | -4,778,265 | $0.00 | $0 | 0 | May 17, 2024 |
Questions about Cystic Fibrosis Foundation
Answered from the filings on this page, as of the latest one.
Is Cystic Fibrosis Foundation buying or selling?
Cystic Fibrosis Foundation has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Cystic Fibrosis Foundation's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Cystic Fibrosis Foundation has 0.
Where does Cystic Fibrosis Foundation file Form 4?
Cystic Fibrosis Foundation has filed Form 4 at HLSQ (BiomX Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.